The development of therapeutic vaccines of the management of malignant melanoma.
Dalgleish
A G
AG
St George's Hospital Medical School, Division of Oncology, London.
Souberbielle
B E
BE
D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D007165:Immunosuppression Therapy; D016233:Immunotherapy, Active; D008545:Melanoma / Q000628:therapy*; D051379:Mice; D009856:Oncogene Proteins, Viral / Q000627:therapeutic use*; D053918:Papillomavirus Vaccines; D012878:Skin Neoplasms / Q000628:therapy*; D014614:Vaccines, Synthetic / Q000627:therapeutic use*; D014765:Viral Vaccines / Q000627:therapeutic use*
D009856:Oncogene Proteins, Viral; D053918:Papillomavirus Vaccines; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; C100344:human papillomavirus vaccine, TA